158 related articles for article (PubMed ID: 15235029)
41. Human melanocyte senescence and melanoma susceptibility genes.
Bennett DC
Oncogene; 2003 May; 22(20):3063-9. PubMed ID: 12789281
[TBL] [Abstract][Full Text] [Related]
42. Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors.
Obana K; Yang HW; Piao HY; Taki T; Hashizume K; Hanada R; Yamamoto K; Tanaka Y; Toyoda Y; Takita J; Tsuchida Y; Hayashi Y
Int J Oncol; 2003 Oct; 23(4):1151-7. PubMed ID: 12963998
[TBL] [Abstract][Full Text] [Related]
43. Genetic predisposition to melanoma.
Skolnick MH; Cannon-Albright LA; Kamb A
Eur J Cancer; 1994; 30A(13):1991-5. PubMed ID: 7734213
[No Abstract] [Full Text] [Related]
44. Melanoma candidate genes CDKN2A/p16/INK4A, p14ARF, and CDK4 sequencing in patients with uveal melanoma with relative high-risk for hereditary cancer predisposition.
Abdel-Rahman MH; Pilarski R; Massengill JB; Christopher BN; Noss R; Davidorf FH
Melanoma Res; 2011 Jun; 21(3):175-9. PubMed ID: 21412176
[TBL] [Abstract][Full Text] [Related]
45. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1.
Zhang S; Ramsay ES; Mock BA
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2429-34. PubMed ID: 9482902
[TBL] [Abstract][Full Text] [Related]
46. Search for genetic variants associated with cutaneous malignant melanoma in the Ashkenazi Jewish population.
Loo JC; Paterson AD; Hao A; Shennan M; Peretz H; Sidi Y; Hogg D; Yakobson E
J Med Genet; 2005 May; 42(5):e30. PubMed ID: 15863662
[No Abstract] [Full Text] [Related]
47. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
Parris CN; Harris JD; Griffin DK; Cuthbert AP; Silver AJ; Newbold RF
Cancer Res; 1999 Feb; 59(3):516-20. PubMed ID: 9973191
[TBL] [Abstract][Full Text] [Related]
48. A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes.
De Simone P; Bottillo I; Valiante M; Iorio A; De Bernardo C; Majore S; D'Angelantonio D; Valentini T; Sperduti I; Piemonte P; Eibenschutz L; Ferrari A; Carbone A; Buccini P; Paiardini A; Silipo V; Frascione P; Grammatico P
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33322357
[TBL] [Abstract][Full Text] [Related]
49. The genetics of cutaneous melanoma.
Pollock PM; Trent JM
Clin Lab Med; 2000 Dec; 20(4):667-90. PubMed ID: 11221509
[TBL] [Abstract][Full Text] [Related]
50. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
[TBL] [Abstract][Full Text] [Related]
51. Chromosome 9p21 and coronary risk--the mystery continues.
Linsel-Nitschke P; Schunkert H
Atherosclerosis; 2011 Feb; 214(2):257-8. PubMed ID: 21146821
[No Abstract] [Full Text] [Related]
52. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
53. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma.
Zuo L; Weger J; Yang Q; Goldstein AM; Tucker MA; Walker GJ; Hayward N; Dracopoli NC
Nat Genet; 1996 Jan; 12(1):97-9. PubMed ID: 8528263
[No Abstract] [Full Text] [Related]
54. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL
Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866
[TBL] [Abstract][Full Text] [Related]
55. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation.
Molven A; Grimstvedt MB; Steine SJ; Harland M; Avril MF; Hayward NK; Akslen LA
Genes Chromosomes Cancer; 2005 Sep; 44(1):10-8. PubMed ID: 15880589
[TBL] [Abstract][Full Text] [Related]
56. 9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor alpha gene alterations.
Perrone F; Tamborini E; Dagrada GP; Colombo F; Bonadiman L; Albertini V; Lagonigro MS; Gabanti E; Caramuta S; Greco A; Torre GD; Gronchi A; Pierotti MA; Pilotti S
Cancer; 2005 Jul; 104(1):159-69. PubMed ID: 15929122
[TBL] [Abstract][Full Text] [Related]
57. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
[TBL] [Abstract][Full Text] [Related]
58. Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia.
Christiansen DH; Andersen MK; Pedersen-Bjergaard J
Leukemia; 2003 Sep; 17(9):1813-9. PubMed ID: 12970781
[TBL] [Abstract][Full Text] [Related]
59. The lack of E318K MITF germline mutation in Latvian melanoma patients.
Ozola A; Pjanova D
Cancer Genet; 2015 Jun; 208(6):355-6. PubMed ID: 25975176
[No Abstract] [Full Text] [Related]
60. Genome-wide linkage scan for atypical nevi in p16-Leiden melanoma families.
de Snoo FA; Hottenga JJ; Gillanders EM; Sandkuijl LA; Jones MP; Bergman W; van der Drift C; van Leeuwen I; van Mourik L; Huurne JA; Frants RR; Willemze R; Breuning MH; Trent JM; Gruis NA
Eur J Hum Genet; 2008 Sep; 16(9):1135-41. PubMed ID: 18398432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]